Skip to content
10-K

Annual Report

BIOPLUS LIFE CORP

0001493152-22-033768

← back to feed
Filed
Nov 28, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Nov 28, 2022 362.27M sh
Capex FY 2021 · Dec 31, 2021 $91.1K
Capex FY 2021 · Dec 31, 2020 $206.46K
Operating Cash Flow FY 2021 · Dec 31, 2021 $193.34K
Operating Cash Flow FY 2021 · Dec 31, 2020 $564.58K
Cash And Equivalents FY 2021 · Dec 31, 2021 $268.26K
Cash And Equivalents FY 2021 · Dec 31, 2020 $398.97K
Stockholders Equity FY 2021 · Dec 31, 2021 $1.9M
Stockholders Equity FY 2021 · Dec 31, 2020 $1.98M
Stockholders Equity FY 2021 · Dec 31, 2019 $1.74M
Current Liabilities FY 2021 · Dec 31, 2021 $828.32K
Current Liabilities FY 2021 · Dec 31, 2020 $1.09M
Total Liabilities FY 2021 · Dec 31, 2021 $1.49M
Total Liabilities FY 2021 · Dec 31, 2020 $1.79M
Current Assets FY 2021 · Dec 31, 2021 $1.15M
Current Assets FY 2021 · Dec 31, 2020 $1.4M
Total Assets FY 2021 · Dec 31, 2021 $3.38M
Total Assets FY 2021 · Dec 31, 2020 $3.77M
Eps Basic FY 2021 · Dec 31, 2021 $0.00
Eps Basic FY 2021 · Dec 31, 2020 $0.00
Sga Expense FY 2021 · Dec 31, 2021 $1.02M
Sga Expense FY 2021 · Dec 31, 2020 $1.07M
Net Income FY 2021 · Dec 31, 2021 $170.73K
Net Income FY 2021 · Dec 31, 2020 $214.19K
Operating Income FY 2021 · Dec 31, 2021 $292.5K
Operating Income FY 2021 · Dec 31, 2020 $288.03K
Gross Profit FY 2021 · Dec 31, 2021 $1.31M
Gross Profit FY 2021 · Dec 31, 2020 $1.37M
Cost Of Revenue FY 2021 · Dec 31, 2021 $1.23M
Cost Of Revenue FY 2021 · Dec 31, 2020 $2.18M
Revenue FY 2021 · Dec 31, 2021 $2.55M
Revenue FY 2021 · Dec 31, 2020 $3.55M